Published

Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuropsychopharmacology
Date: 2026-07-01
Source: Crossref
DOI: 10.1038/s41386-026-02428-9
PubMed: 42049943

Authors

Arikci Denis Borgulya Joran Straumann Isabelle Vizeli Patrick Luethi Dino Thomann Jan Rudin Deborah Vukalovic Ina Eckert Anne Liechti Matthias E.Holze Friederike

Watch author

Derived topics and classifications

psilocybin Depression Anxiety PTSD Pharmacology Consciousness Emotional Processing In Vitro Study Healthy Volunteers Clinical Trial

Citation graph

40 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1038/s41591-021-01336-3 10.1038/s41591-023-02565-4 10.1001/jama.2023.14530 10.1056/nejmoa2206443 10.1192/bjp.2025.10320 10.1177/02698811251362390 10.1016/j.drugalcdep.2015.10.011 10.1016/j.neuropharm.2015.08.034 10.1097/00001756-199812010-00024 10.1177/2050324515578080 10.1093/jat/23.3.227 10.1016/j.pnpbp.2010.10.018

Indexed papers citing this DOI

Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants2026-07-01

Related papers

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 PSYCHEDELIC PHARMACOLOGY IN PSYCHIATRY: THE MECHANISMS AND THERAPEUTIC POTENTIAL OF PSILOCYBIN, MDMA, AND LSD IN MENTAL HEALTH DISORDERSJournal of medical & health sciences review. · 2025-03-11